News
Kuppusamy noted that Quest does offer testing, and advanced diagnostic testing in particular, through its Global Diagnostics ...
The firm reported that its total revenues jumped 9 percent in Q2, but it lowered the low end of its EPS guidance to account for the uncertainty of tariffs and other trade barriers.
NEW YORK – Although it had multiple products with regulatory clearance and technology that had been validated by outside users, Accelerate Diagnostics' inability to attract buyers for its instruments ...
The money will support the development of the firm's PidPort system for storage, viewing, sharing, and analysis of digital images of pathology slides.
NEW YORK – The World Health Organization announced on Friday that its Medicines Patent Pool has sublicensed technology for rapid diagnostic testing to Nigeria’s Codix Bio.
Congress has passed delays to PAMA implementation, but such a pause could be less likely this year, warn industry stakeholders.
April's clearances included respiratory disease assays, a Gram-negative infection test, and assays to aid the diagnosis and monitoring of thyroid disease.
The firm has been engaging with payors and insurance plan administrators following the release of results from its study on the use of the firm's PreTRM Test.
The firm reported growth across its immunodiagnostics and molecular diagnostics businesses as well as contributions from the firm's licensed technologies business.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results